(thirdQuint)A Non-interventional, Observational Study for Targinact Treatment in Patients With Chronic Severe Pain.

 Patients are treated with Targinact(R) according to daily clinical practice during at least 12 weeks and are monitored during study 3 visits.

 Parameters assessed are pain relief, constipation, use of laxatives, use of analgesic rescue medication, use of concomitant medication, quality of life and safety of Targinact(R) treatment.

 These parameters, except for safety assessment, are compared between Targinact(R) treatment and previous analgesic treatment with prolonged release oxycodone.

.

 A Non-interventional, Observational Study for Targinact Treatment in Patients With Chronic Severe Pain@highlight

This non-interventional, observational study is set up on request of the Belgian reimbursement authorities and evaluates the efficacy of Targinact with regard to pain relief and constipation in daily clinical practice in Belgium compared to the previous analgesic treatment with prolonged release oxycodone.

 Only patients eligible for Targinact(R) reimbursement in Belgium are included.

